Trinity Biotech plc Skyrocketed
Tue, Jan 28, 2025 at 07:25 PM
Trinity Biotech plc (TRIB:NASDAQ) rocketted at $1.36, representing a gain of 78.9%. On Tue, Jan 28, 2025, TRIB:NASDAQ hit a New 2-Week High of $1.36. The stock appeared on our News Catalysts scanner on Tue, Jan 28, 2025 at 09:32 AM in the 'BIOTECH' category. From Tue, Jan 14, 2025, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Tue, Aug 27, 2024 at $3.39 with a volume of 69M+.
About Trinity Biotech plc (TRIB:NASDAQ)
Trinity Biotech PLC develops, manufactures and markets clinical diagnostic products. Its products are used for detecting autoimmune, sexually transmitted diseases, diabetes and disorders of the liver.
Top 10 Gainers:
- F45 Training Holdings Inc. (FXLV:NYSE), 269.23%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 168.26%
- Biomotion Sciences (SLXN:NASDAQ), 132.76%
- Trinity Biotech plc (TRIB:NASDAQ), 78.95%
- Planet Image International Limited (YIBO:NASDAQ), 66.88%
- Diginex Limited (DGNX:NASDAQ), 59.13%
- IMAC Holdings Inc. (BACK:NASDAQ), 47.17%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 45.53%
- LatAmGrowth SPAC (LATG:NASDAQ), 40%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 34.97%